Serum phosphorus · people with CKD‐MBD
1 finding from 1 review
FGF‐23 · people with CKD‐MBD
1 finding from 1 review
PTH · people with CKD‐MBD
1 finding from 1 review
All‐cause mortality · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular events · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fracture · people with CKD‐MBD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants with symptomatic UTI · primary VUR
Antibiotic prophylaxis showed no clear difference in symptomatic UTI; antibiotics versus placebo in trials with low risk… compared with surveillance or no treatment (moderate certainty).
1 finding from 1 review
Intervention not reported
PLACEBO · CKD patients (any stage) treated for anaemia
1 finding from 1 review
Intervention not reported
Symptomatic bacterial UTI in adults and children in patients with and without recurrent UTI Probiotics versus placebo ( · adults and children at risk of UTI
The intervention showed no clear difference in symptomatic bacterial UTI in adults and children in patients with… (low certainty).
1 finding from 1 review
Intervention not reported
Symptomatic bacterial UTI in adults and children with recurrent UTI Probiotics versus placebo ( · adults and children at risk of UTI
The intervention showed no clear difference in symptomatic bacterial UTI in adults and children with recurrent UTI… (low certainty).
1 finding from 1 review
Intervention not reported
Symptomatic bacterial UTI in children with VUR Probiotics versus placebo ( · adults and children at risk of UTI
The intervention showed no clear difference in symptomatic bacterial UTI in children with VUR Probiotics versus… (low certainty).
1 finding from 1 review
Vertebral fracture by radiography · postmenopausal women with osteoporosis and CKD stages 3‐4
Any anti‐osteoporotic drugs may leads to lower vertebral fracture by radiography compared with placebo (low certainty).
1 finding from 1 review
Vertebral fracture by radiography · postmenopausal women with osteoporosis and CKD stages 5 and 5D
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Clinical fracture · postmenopausal women with osteoporosis and CKD stages 5 and 5D
It is very uncertain whether raloxifene changes clinical fracture compared with placebo (very low certainty).
1 finding from 1 review
Mean change in BMD of the femoral neck · postmenopausal women with osteoporosis and CKD stages 5 and 5D
It is very uncertain whether raloxifene changes mean change in BMD of the femoral neck compared with placebo (very low certainty).
1 finding from 1 review
Mean change in BMD of the lumbar spine · postmenopausal women with osteoporosis and CKD stages 5 and 5D
Raloxifene may leads to higher mean change in BMD of the lumbar spine compared with placebo (low certainty).
1 finding from 1 review
Total hip BMD · postmenopausal women with osteoporosis and CKD stages 5 and 5D
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean change in BMD of the distal radius · postmenopausal women with osteoporosis and CKD stages 5 and 5D
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · postmenopausal women with osteoporosis and CKD stages 5 and 5D
1 finding from 1 review
Death · postmenopausal women with osteoporosis and CKD stages 5 and 5D
It is very uncertain whether raloxifene changes death compared with placebo (very low certainty).
1 finding from 1 review